Sernova Corp T.SVA

SVA POTENTIAL TO HAVE $96 Million in Cash

[steadfast]

Warrants:
25M in Aug & Sept       $ 8M  at 30-35 cents, a for sure  deal
20M March @ 1.70        34M  accelerate upon $3.05 per share
Evotec                          27M
Cash as at Jan 31          27M
Total                            $96M
That should get the attention of Big Pharma + Analysts recommending SVA, all
with targets over $3.00.  We have the most beautiful Chart with a Fibonacci screaming
for a weekly close over $1.60 so the stock can reach next target of Minimum $3.75,
and ideally it should go to the 1.618 extension which is all the way up to $5.50.

The Scientists have performed - now it is time for the I.R. guys to perform, they have
been given a gift on a silver platter - if they don't soon get this stock on a weekly close
above $1.60 - Big Pharma will take us out for a song.    The iPSC DEAL should be
worth another $1B to SVA and our stock sits at $1.46.   SOMETHING IS WRONG.
Don;t take my word, look at the Chart, ask your buddies who participate in Fibonacci.

[donkeyfeathers]

Here's a consideration SF, Right now it's the banksters and investment houses (LJ & CC) that are maintaining the rangebound price tag (i.e. between them and the IR guys in house, they have an agenda to short whenever they want). There is so much chatter about institutional investors picking up shares when the uplisting happens, and no doubt there will be SOME interest.  But there&

[BioTeck]

Nothign wrong with having cash on hand but not when it comes with massive dilution. If they could get a proper IR team to start promoting the stock and get the price up to where it deserves to be, they could easily raise more capital with less dilution with strong institutions instead of whoring themselves out to the lowest bidder who ends up abusing sva after blowing their load all over her

[steadfast]

Thank you, DF.  I knew I could count on you to offer Words of Wisdom. I had considered similar thoughts this past while and grateful to have possible confirmation.  However, I was not aware Big Pharma can hold 4% of a Co without declaring. The ? is Why are SVA spending thousands of $'s on I.R. if  the Devils maybe holding SVA range bound?  Have SVA hired the quality of I.R

[donkeyfeathers]

I would assume that if a competitor held stock in SVA it would be through a proxy (so it appears as indirect investment).  And this type of situation where a publically traded company gets manipulated on the path to overcoming the goals of those who do not want to have their business model disrupted, needs both the great science people, and even greater business acumen (sniff out and get rid

[steadfast]

Thank You DF, another Excellent Post. Soon we will be uplifted to the TSE, consequently it is the responsibility of each one who Posts to raise their level of professionalism in their posts.  We want to ensure the New Investors learn from this Bullboard of the potential gem they may have and forget the nonsense that is so unprofessional. Not only do we have a beautiful chart in terms of